Mateon Therapeutics Inc Share Price OTC Bulletin Board
Equities
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2022 | - | Sales 2023 | 0.07 5.85 | Capitalization | 15.27M 1.28B |
---|---|---|---|---|---|
Net income 2022 | 5M 418M | Net income 2023 | -7M -585M | EV / Sales 2022 | - |
Net Debt 2022 | 11.02M 920M | Net Debt 2023 | 12.4M 1.04B | EV / Sales 2023 | 39,53,16,686 x |
P/E ratio 2022 |
4.5
x | P/E ratio 2023 |
-1.91
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 45.03% |
Managers | Title | Age | Since |
---|---|---|---|
Vuong Trieu
CEO | Chief Executive Officer | 59 | 22/19/22 |
Director of Finance/CFO | 57 | 01/19/01 | |
Seymour H. Fein
CTO | Chief Tech/Sci/R&D Officer | 75 | 06/20/06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Steven King
BRD | Director/Board Member | 59 | 11/20/11 |
Anthony Maida
CTO | Chief Tech/Sci/R&D Officer | 59 | 11/20/11 |
Vuong Trieu
CEO | Chief Executive Officer | 59 | 22/19/22 |
1st Jan change | Capi. | |
---|---|---|
+3.91% | 109B | |
+10.87% | 105B | |
+1.28% | 22.25B | |
-13.14% | 22.09B | |
-7.05% | 18.68B | |
-38.36% | 17.58B | |
-10.66% | 16.85B | |
+3.75% | 13.76B | |
+36.70% | 12.46B |